FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
100 letters match. Newest first.
-
DevicesPro-Optics, LLC
FDA warned Pro-Optics about unapproved material and color changes to contact lens cases and quality system failures.
Medium -
BiologicsTides Medical LLC
FDA warns Tides Medical over APLICOR 3D wound device sold without approval, exemption, or required FDA notice.
High risk -
DevicesO.N. Diagnostics, LLC
FDA says O.N. Diagnostics sold changed VirtuOst VFA software without required clearance and had quality and reporting failures.
High risk -
DevicesAdvance-Esthetic LLC
FDA says Advance-Esthetic markets three Zemits body-contouring devices without the required FDA clearance or approval.
Medium -
BiologicsStephen J. Fallon, Ph.D.
FDA warns clinical investigator Stephen J. Fallon, Ph.D. over consent and record failures in an HIV self-test study.
High risk -
DevicesNihon Kohden Digital Health Solutions, LLC
FDA says Nihon Kohden Digital Health Solutions sold an uncleared monitor software change that can silence life-threatening alarms.
High risk -
DevicesSkytron, LLC
Skytron marketed four UV disinfection devices without FDA clearance or approval and kept unapproved medical claims after promising to remove them.
High risk -
DevicesAseptiKits, LLC
AseptiKits marketed unapproved sterile-preparation device kits without FDA clearance or approval, FDA says.
High risk -
DevicesBMC Medical Co., Ltd.
BMC Medical’s G3X APAP devices were misbranded/adulterated after significant changes without a new 510(k) and an unreported firmware fix.
High risk -
DevicesHappiest Baby, Inc.
FDA says Happiest Baby marketed unapproved SNOO sleep sacks and hospital bundle and mishandled complaints.
High risk -
BiologicsEstar Technologies Ltd
FDA warns Estar Technologies over selling seven unapproved PRP/PRF device kits in the U.S. without clearance or approval.
High risk -
DevicesUnetixs Vascular, Inc.
Unetixs Vascular marketed modified ROODRA and 2CP vascular diagnostic devices without required FDA clearance.
High risk -
Biologics4U Health
FDA says 4U Health sells an unapproved HIV dried blood spot self-collection kit, making it adulterated and misbranded.
High risk -
DevicesDiasol, Inc.
Diasol sold unapproved citric acid hemodialysis disinfectants and had quality system violations, FDA says.
High risk -
DevicesExThera Medical Corporation
ExThera shipped Seraph 100 blood filters for compassionate use without FDA approval and promoted them as approved.
High risk -
BiologicsProDx Health
FDA warns ProDx Health that its HIV sample self-collection kits are sold without marketing authorization.
High risk -
BiologicsGermaphobix
FDA warns Germaphobix that its unapproved HIV dried blood spot self-collection kit is adulterated and misbranded.
High risk -
BiologicsGenetrace
FDA warned Genetrace that its HIV dried blood spot self-collection kit is unapproved and misbranded.
High risk -
BiologicsGenovate
FDA warns Genovate over selling an unapproved HIV dried-blood-spot self-collection kit without marketing authorization.
High risk -
DevicesLifeVac, LLC
FDA warns LifeVac it is selling its Rescue Suction Device without required FDA approval.
High risk -
DevicesSeniorLife Technologies, Inc.
FDA warns SeniorLife Technologies that its SeniorLife.AI app is unapproved and misbranded, with quality-system and reporting failures.
High risk -
DevicesUscom Kft
Uscom Kft marketed SpiroSonic AIR spirometer in the U.S. without FDA clearance and had multiple quality system failures at its Budapest plant.
High risk -
BiologicsO3UV, LLC
FDA warns O3UV that its Champion and EBOO ozone/UV blood devices are unapproved, misbranded, and made without required quality controls.
High risk -
DevicesWHOOP, Inc.
FDA warns WHOOP it markets Blood Pressure Insights without device clearance or approval.
High risk -
DevicesDRG Instruments GmbH
FDA warns DRG Instruments over unapproved salivary cortisol ELISA devices and quality system and reporting violations.
High risk -
DevicesUnited Health Products, Inc.
FDA warns United Health Products over unapproved significant-risk study of CelluSTAT absorbable hemostat and trial oversight failures.
High risk -
DevicesICU Medical
ICU Medical warned for changed Medfusion 4000 and CADD Solis infusion pumps sold without required FDA clearances.
High risk -
DevicesNext Science LLC
FDA warns Next Science that wound gels and irrigation solutions are adulterated and misbranded for uncleared claims and quality failures.
High risk -
DevicesRex Implants Inc.
Rex Implants warned for unapproved dental implant devices and uncleared changes to its cleared implant system.
High risk -
DevicesExer Labs, Inc.
Exer Labs marketed its Exer Scan device for AI diagnosis and treatment without FDA approval or clearance and lacked quality procedures.
High risk -
DevicesRed Oak Instruments, LLC
Red Oak Instruments marketed RU-Fit dynamometer for concussion screening without FDA clearance and had MDR and quality system violations.
High risk -
DevicesQ’Apel Medical, Inc.
Q’Apel Medical marketed an uncleared modified HIPPO stroke aspiration device and had quality system violations, FDA says.
High risk -
DevicesAnne’s Daye Ltd dba Tampon Innovations
FDA says Anne’s Daye marketed CBD-coated tampons and vaginal screening kits without required device clearance or approval.
High risk -
BiologicsBlackfly Investments, LLC dba Molecular® Testing Labs
Blackfly Investments dba Molecular Testing Labs sells an HIV dried blood spot self-collection kit without FDA marketing authorization.
High risk -
DevicesMid-Link Testing Company, Ltd
FDA warns Mid-Link Testing over unreliable Good Laboratory Practice (GLP) safety data for medical device tests.
High risk -
DevicesSanitation & Environmental Technology Institute dba SDWH
FDA found GLP violations in SDWH's nonclinical testing of medical devices, raising doubts about safety data.
High risk -
DevicesShenzhen Moyeah Intelligent Life Technology Co.
Shenzhen Moyeah sold ozone and UV CPAP cleaner and sanitizer devices in the U.S. without FDA clearance or approval, FDA says.
High risk -
DevicesLEEL Tech
FDA warns LEEL Tech that its CLYN, LEEL, and SOLID CPAP cleaners/sanitizers are sold in the U.S. without required clearance or approval.
Medium -
DevicesAdventure Innovations LLC
FDA says Adventure Innovations sold Sani Bot D3, a CPAP cleaner, without device clearance or approval.
Medium -
DevicesNatures Pillows, Inc. and Top Dog Direct, LLC
FDA warns Natures Pillows and Top Dog Direct that Clean Zone CPAP Sanitizer is an unapproved, misbranded device.
High risk -
DevicesBaylab USA, LLC
Baylab USA sold unapproved Level 1 masks, KN95 respirators and unclear colors and kids' versions of its Level 3 mask, FDA says.
High risk -
DevicesAG Essence, Inc.
FDA warned AG Essence that its Banda-SiL silver wound gels are adulterated and misbranded because they are sold without required FDA marketing clearance.
High risk -
DevicesTrexo Robotics Holdings Inc.
FDA warns Trexo Robotics over unapproved robotic gait-training legs for children and design-control gaps at its Canadian plant.
High risk -
DevicesOstar Beauty Sci-Tech Co Ltd.
FDA warned Ostar Beauty Sci-Tech, a Chinese maker of microneedling pens, LED masks and fat-freezing pads, for selling unapproved medical devices in the US.
High risk -
DevicesCardinal Health
Cardinal Health marketed convenience kits with unapproved syringes and lacked supplier qualification for infusion-pump-compatible Monoject syringes.
High risk -
DevicesSoulaire Corporation
FDA says Soulaire marketed an ECP device for unapproved uses without clearance or approval.
High risk -
DevicesAgena Bioscience, Inc.
Agena Bioscience marketed its iPLEX HS Colon Panel with the MassARRAY4 System for clinical diagnosis without FDA clearance or approval.
High risk -
DevicesReNovo, Inc. DBA Provision Device Reprocessing Solutions
ReNovo, a device reprocessor in Bend, Oregon, sold new device models without required FDA clearances and had quality system failures.
High risk -
DevicesJiangsu Shenli Medical Production Co., Ltd.
FDA says Jiangsu Shenli marketed many piston syringes in the U.S. without required clearance or approval.
High risk -
DevicesSol-Millennium Medical, Inc.
Sol-Millennium marketed modified syringes and needles without required FDA clearance and had quality-system and reporting violations.
High risk